Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liver-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liver

Published:2018-03 Issue: Volume:114 Page:55-63
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Murray Michael^ORCID,Gillani Tina B.,Ghassabian Sussan^ORCID,Edwards Robert J.,Rawling Tristan

Funder

Cancer Council NSW

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference55 articles.

1. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma;Abou-Alfa;J. Clin. Oncol.,2006

2. Sorafenib exposure decreases over time in patients with hepatocellular carcinoma;Arrondeau;Investig. New Drugs,2012

3. CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6α-hydroxylase activity in human liver microsomes;Bahadur;Biochem. Pharmacol.,2002

4. Pharmacokinetics of erythromycin in patients with severe cirrhosis. Respective influence of decreased serum binding and impaired liver metabolic capacity;Barre;Br. J. Clin. Pharmacol.,1987

5. Imatinib mesylate therapy in patients with gastrointestinal stromal tumors and impaired liver function;Bauer;Anti-Cancer Drugs,2002

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Berberis vulgaris, and its active constituent berberine on cytochrome P450: a review;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-14

2. Physiologically‐based pharmacokinetic modeling predicts the drug interaction potential of GLS4 in co‐administered with ritonavir;CPT: Pharmacometrics & Systems Pharmacology;2024-06-20

3. Pharmacokinetic considerations for angiogenesis inhibitors used to treat hepatocellular carcinoma: an overview;Expert Opinion on Drug Metabolism & Toxicology;2023-10-20

4. Incorporation and Performance Verification of Hepatic Portal Blood Flow Shunting in Minimal and Full PBPK Models of Liver Cirrhosis;Clinical Pharmacology & Therapeutics;2023-09-09

5. A Validated 2D-LC-UV Method for Simultaneous Determination of Imatinib and N-desmethylimatinib in Plasma and its Clinical Application for Therapeutic Drug Monitoring with GIST Patients;Current Pharmaceutical Analysis;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3